Banker Haris Santana argues that apps have made banking quicker, but customer trust is still won by people who explain, help and act when something goes wrong.
Mobile apps have taken much of the waiting out of banking.
FI Works founder Keith Henkel says community banks and credit unions have the data, but lack a way to turn a warning sign into a call to the right person.
FI Works, which builds a relationship intelligence and engagement platform for community banks and credit unions, has launched Signals, a feature that uses machine learning to spot households likely to add a product, take up digital services or leave the
Netcall's Pol Brouckaert argues that as AI makes fake documents easier to produce, checks on whether evidence can be trusted must sit inside workflows.
Businesses have spent years automating the processing of claims, applications and supporting documents.
Deel's Alex Bouaziz and Clarity's Michael Matias explain why a one-off identity check at hiring no longer holds as deepfake candidates reach real interviews.
Deel, the global people platform, has acquired Clarity, an AI cybersecurity company that specialises in identity verification, deepfake detection and fraud prevention.
Build an investment platform around investor trust and clear business goals—not appearances. Prioritize investor conversations, practical systems, and an aligned team.
If you’re thinking about launching an institutional investment platform, the legal side is only part of the story.
Experian's Power Profile Plus update lets mortgage lenders access full credit profiles via soft inquiry, cutting early-stage costs as modern scoring goes mainstream.
Experian's Power Profile Plus update lets mortgage lenders access full credit profiles via soft inquiry, cutting early-stage costs as modern scoring goes mainstream.
Nasdaq-listed Solmate says it plans to resell UAE-sourced GPU capacity for AI training and inference, with payment options including Solana stablecoins.
The EMA's advisory committee recommended secukinumab for patients aged 12 and over with moderate to severe hidradenitis suppurativa, with an EC decision expected within